Analystreport

Seelos Therapeutics, Inc. (NASDAQ: SEEL) was downgraded by analysts at Roth Capital from a "buy" rating to a "neutral" rating.

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report